• No results found

University of Groningen Paediatric cardiomyopathies Herkert, Johanna Cornelia

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Paediatric cardiomyopathies Herkert, Johanna Cornelia"

Copied!
11
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Paediatric cardiomyopathies

Herkert, Johanna Cornelia

DOI:

10.33612/diss.97534698

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Herkert, J. C. (2019). Paediatric cardiomyopathies: an evolving landscape of genetic aetiology and

diagnostic applications. Rijksuniversiteit Groningen. https://doi.org/10.33612/diss.97534698

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Paediatric cardiomyopathies

An evolving landscape of genetic aetiology

and diagnostic applications

(3)

ISBN (printed version): 978-94-034-1899-5 ISBN (electronic version): 978-94-034-1898-8 Cover design and layout: © evelienjagtman.com Printing: Ipskamp Printing, Enschede, the Netherlands

Printing of this thesis was financially supported by the Graduate School of Medical Sciences, University Medical Center Groningen, the Netherlands

© 2019, J.C. Herkert, the Netherlands

All rights reserved. No part of this thesis may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, without prior permission of the author or, when appropriate, of the publisher of the publications included in this thesis.

(4)

Paediatric cardiomyopathies

An evolving landscape of genetic aetiology and diagnostic applications

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. C. Wijmenga en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op woensdag 16 oktober 2019 om 11.00 uur

door

Johanna Cornelia Herkert

geboren op 27 februari 1981 te Epe

(5)

Promotores

Prof. dr. I.M. van Langen Prof. dr. M.P. van den Berg

Copromotor

Dr. J.D.H. Jongbloed

Beoordelingscommissie

Prof. dr. M.M.A.M. Mannens Prof. dr. N.A. Blom

(6)

Paranimfen

Mieke Kerstjens Cyrille Herkert

Voor Maria, Marije, Jeffrey, Engbert, Yoni, Antine, Rianne, Sharona, Sophie, Dylan, Jade, Asya, Mart, Lauri, Eslem, Naomi, Kick, Sander, Tiger, Hendrik, Jeroen, Michiel, Mart, Marlies, Felicia, Emam, Kaiden, Twan, Stef, Ilse, Jarno, Matthijs, Eva, Oemaima, Sylvia, Abdulsamet, Peter, Rick, Jefta, Mart, Jette, Koen, Monica, Meike, Noelle,

(7)
(8)

Contents

Part I Introduction

Chapter 1 General Introduction & Aims and outline of this thesis 11 Chapter 2 Clinical utility gene card for: dilated cardiomyopathy (CMD) 39 Chapter 3 Compound heterozygous or homozygous truncating MYBPC3

mutations cause lethal cardiomyopathy with features of noncompaction and septal defects

57

Part II Yield and strategies for genetic testing and data analysis

Chapter 4 Toward an effective exome-based genetic testing strategy in paediatric dilated cardiomyopathy

81 Chapter 5 Improving the diagnostic yield of exome-sequencing by predicting

gene-phenotype associations using large-scale gene expression analysis

147

Part III Rare and novel genes

Chapter 6 Novel SPEG mutations in congenital myopathies: genotype-phenotype correlations

185 Chapter 7 Biallelic truncating mutations in ALPK3 cause severe paediatric

cardiomyopathy

201 Chapter 8 Expanding the clinical and genetic spectrum of ALPK3 variants:

phenotypes identified in paediatric cardiomyopathy patients and adults with heterozygous variants

229

Chapter 9 Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy

287

Part IV Summary and general discussion

Chapter 10 Summary 319

Chapter 11 Discussion and future perspectives 327

Appendix

Nederlandse samenvatting List of abbreviations

List of authors and affiliations Curriculum vitae List of publications Dankwoord 347 255 361 373 377 385

(9)
(10)

Introduction

(11)

Referenties

GERELATEERDE DOCUMENTEN

Because of our leave-one-out procedure when calculating prioritization Z-scores for known disease genes (see Methods), our performance in solved cases is indicative of the power of

Generally, type 1 fibers were smaller in diameter (hypotrophy), while type 2 fibers were larger compared to an age- matched control Increased fiber size variability Hypotrophy

Patient A-IX:2 was found to carry a homozygous intronic variant in the consensus acceptor splice site sequence of exon 10 of the ALPK3 gene (c.4736-1G>A) (Figure 3), and

Based on a combination of the major shared phenotypic abnormalities in our patients, the ALPK3 gene is ranked in the top 1% of all coding and non-coding human genes

25,34 Since no deficiency was seen in any of the mitochondrial respiratory chain complexes I-V, the significant increase in O 2 −• is likely explained by the

We show that whole exome sequencing (WES) with step-wise analysis of (i) well-known cardiomyopathy genes, (ii) copy number variants (CNVs), (iii) all genes assigned to

After discussion in an interdisciplinary board over unsolved cases with further targeted genetic testing, another five patients were shown to have pathogenic variants in

Amor, Bruce Lefroy Centre for Genetic Health Research, Murdoch Children’s Research Institute, Victoria, Australia; Department of Pediatrics, Faculty of Medicine, Dentistry and